BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19811509)

  • 1. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome.
    Erickson D; Erickson B; Watson R; Patton A; Atkinson J; Meyer F; Nippoldt T; Carpenter P; Natt N; Vella A; Thapa P
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):793-9. PubMed ID: 19811509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.
    Kasaliwal R; Sankhe SS; Lila AR; Budyal SR; Jagtap VS; Sarathi V; Kakade H; Bandgar T; Menon PS; Shah NS
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):825-30. PubMed ID: 23061773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
    Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours.
    Stobo DB; Lindsay RS; Connell JM; Dunn L; Forbes KP
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):673-7. PubMed ID: 21609346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm.
    Walia R; Gupta R; Bhansali A; Pivonello R; Kumar R; Singh H; Ahuja C; Chhabra R; Singh A; Dhandapani S; Sahoo S; Rana N; Vatsa R; Dutta P; Kumar Bhadada S; Sachdeva N; Mittal BR; Nahar U; Shukla J
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1816-e1826. PubMed ID: 33079979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
    Tabarin A; Laurent F; Catargi B; Olivier-Puel F; Lescene R; Berge J; Galli FS; Drouillard J; Roger P; Guerin J
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):293-300. PubMed ID: 9861318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging diagnostic methods and imaging modalities in cushing's syndrome.
    Wright K; van Rossum EFC; Zan E; Werner N; Harris A; Feelders RA; Agrawal N
    Front Endocrinol (Lausanne); 2023; 14():1230447. PubMed ID: 37560300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
    Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
    Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
    Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location.
    Graham KE; Samuels MH; Nesbit GM; Cook DM; O'Neill OR; Barnwell SL; Loriaux DL
    J Clin Endocrinol Metab; 1999 May; 84(5):1602-10. PubMed ID: 10323387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.
    Oldfield EH; Doppman JL; Nieman LK; Chrousos GP; Miller DL; Katz DA; Cutler GB; Loriaux DL
    N Engl J Med; 1991 Sep; 325(13):897-905. PubMed ID: 1652686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in Cushing's syndrome.
    Sahdev A; Reznek RH; Evanson J; Grossman AB
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1319-28. PubMed ID: 18209870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.